What is the current market valuation of the US dupuytren s-contracture market?

The market valuation was $921.9 Million in 2024. Read More

What is the projected market size for the US dupuytren s-contracture market by 2035?

The projected market size is $1690.0 Million by 2035. Read More

What is the expected CAGR for the US dupuytren s-contracture market during the forecast period 2025 - 2035?

The expected CAGR is 5.66% during the forecast period 2025 - 2035. Read More

Which companies are key players in the US dupuytren s-contracture market?

Key players include AbbVie Inc, Bausch Health Companies Inc, MediWound Ltd, Revance Therapeutics Inc, Sientra Inc, Sanofi, Merz Pharmaceuticals GmbH, and Ipsen S.A. Read More

What are the different types of dupuytren s-contracture segments and their valuations?

Type I was valued at $276.57 Million, Type II at $368.76 Million, and Type III at $276.57 Million. Read More

How does the diagnosis segment perform in the US dupuytren s-contracture market?

The diagnosis segment includes Physical Examination at $300.0 Million, X-ray at $200.0 Million, and Others at $421.9 Million. Read More

What are the drug segments available for treating dupuytren s-contracture?

Drug segments include Collagenase Injection at $300.0 Million, Immune-Modulator at $200.0 Million, Steroids at $150.0 Million, and Others at $271.9 Million. Read More

What therapies are utilized in the treatment of dupuytren s-contracture?

Therapies include Radiation Therapy at $100.0 Million, Physiotherapy at $300.0 Million, and Others at $521.9 Million. Read More

What are the end-user segments in the US dupuytren s-contracture market?

End-user segments consist of Hospitals and Clinics at $400.0 Million, Academic and Research at $300.0 Million, and Others at $221.9 Million. Read More

How does the market for dupuytren s-contracture appear to be evolving?

The market appears to be growing steadily, with a projected increase to $1690.0 Million by 2035, indicating robust demand. Read More

US Dupuytren’s Contracture Market

US Dupuytren's Contracture Market Research Report By Type (type I, type II, type III), By Therapy (radiation therapy, physiotherapy, others), By Diagnosis (physical examination, x-ray, others), By Drugs (Steroids, collagenase injection, immune-modulators, others) and By End User (hospitals & clinics, academic and research, others) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

5.66%

2024 Market Size

$ 921.9 Million

2035 Market Size

$ 1,690 Million

Pharmaceutical ● Updated August 2026 Report ID: MRFR/Pharma/18377-HCR | Pages: 100 | Author: Satyendra Maurya, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Type (USD Million)
  1. 4.1.1 Type I
  2. 4.1.2 Type II
  3. 4.1.3 Type III
2. 4.2 Medical Device, BY Diagnosis (USD Million)
  1. 4.2.1 Physical Examination
  2. 4.2.2 X-ray
  3. 4.2.3 Others
3. 4.3 Medical Device, BY Drugs (USD Million)
  1. 4.3.1 Collagenase Injection
  2. 4.3.2 Immune-Modulator
  3. 4.3.3 Steroids
  4. 4.3.4 Others
4. 4.4 Medical Device, BY Therapy (USD Million)
  1. 4.4.1 Radiation Therapy
  2. 4.4.2 Physiotherapy
  3. 4.4.3 Others
5. 4.5 Medical Device, BY End-User (USD Million)
  1. 4.5.1 Hospitals and Clinics
  2. 4.5.2 Academic and Research
  3. 4.5.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 AbbVie Inc (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Bausch Health Companies Inc (CA)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 MediWound Ltd (IL)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Revance Therapeutics Inc (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Sientra Inc (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Sanofi (FR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Merz Pharmaceuticals GmbH (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Ipsen S.A. (FR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY DIAGNOSIS
4. 6.4 US MARKET ANALYSIS BY DRUGS
5. 6.5 US MARKET ANALYSIS BY THERAPY
6. 6.6 US MARKET ANALYSIS BY END-USER
7. 6.7 KEY BUYING CRITERIA OF MEDICAL DEVICE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF MEDICAL DEVICE
10. 6.10 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
12. 6.12 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
14. 6.14 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
15. 6.15 MEDICAL DEVICE, BY DIAGNOSIS, 2024 (% SHARE)
16. 6.16 MEDICAL DEVICE, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
17. 6.17 MEDICAL DEVICE, BY DRUGS, 2024 (% SHARE)
18. 6.18 MEDICAL DEVICE, BY DRUGS, 2024 TO 2035 (USD Million)
19. 6.19 MEDICAL DEVICE, BY THERAPY, 2024 (% SHARE)
20. 6.20 MEDICAL DEVICE, BY THERAPY, 2024 TO 2035 (USD Million)
21. 6.21 MEDICAL DEVICE, BY END-USER, 2024 (% SHARE)
22. 6.22 MEDICAL DEVICE, BY END-USER, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY DIAGNOSIS, 2025-2035 (USD Million)
  3. 7.2.3 BY DRUGS, 2025-2035 (USD Million)
  4. 7.2.4 BY THERAPY, 2025-2035 (USD Million)
  5. 7.2.5 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Dupuytren’s Contracture Market Segmentation

US Dupuytren’s Contracture Market By Type (USD Million, 2025-2035)

Type I
Type II
Type III

US Dupuytren’s Contracture Market By Diagnosis (USD Million, 2025-2035)

Physical Examination
X-ray
Others

US Dupuytren’s Contracture Market By Drugs (USD Million, 2025-2035)

Collagenase Injection
Immune-Modulator
Steroids
Others

US Dupuytren’s Contracture Market By Therapy (USD Million, 2025-2035)

Radiation Therapy
Physiotherapy
Others

US Dupuytren’s Contracture Market By End-User (USD Million, 2025-2035)

Hospitals and Clinics
Academic and Research
Others

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”